ATM and COVID-19: These facts suggest probable viral antigen(s) in SARS-CoV-2 target the spinal cord –perhaps also present in the COVID-19 vaccine AZD1222 or its chimpanzee adenovirus adjuvant– and may induce immune mechanisms leading to ATM.